Pfizer Ltd. Financials

NSE BSE

15:57 Jul 18

Pfizer Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

5319.50

-42.50 (-0.79%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

5319.50

-42.50 (-0.79%)
15:57 Jul 18

Quality

79/100
High Financial Strength

Valuation

38/100
Mid Valuation

Technical

47/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Nov 2006	Nov 2007	Nov 2008
Net Sales	733.7	735.6	733.2
Operating Expenses +	568.02	579.1	580.77
Raw Material	246.68	238.95	271.31
Increase Decrease in Cost	-10.25	4.77	-22.49
Other Manufacturing Expense	26.8	29.05	30.99
Employee Cost	102.34	101.7	102.1
Miscellaneous Expenses	417.35	383.81	348.78
Operating Profit	165.68	156.5	152.43
Other Income	33.47	319.87	66.02
Depreciation	13.07	9.58	11.12
Interest	0.07	0.02	0
Profit before tax and exceptio..	186.01	466.76	207.33
Exceptional Items	0	0	0
PBT	186.01	466.76	207.33
Provision for Taxation	56.31	111.34	119.56
Net Profit	106.33	340	299.57
NET Profit after MI	106.33	340	299.57
EPS	35.63	113.93	100.38
Operating Profit Margin (%)	22.58	21.28	20.79
Net Profit Margin (%)	14.49	46.22	40.86

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	63.90	63.90	63.90	63.90	63.90
FII	2.40	2.20	2.70	3.50	3.20
MF	11.70	11.60	11.30	10.40	8.30
Others	5.50	5.50	5.50	5.70	7.50

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: